Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Clear-cell Kidney Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT04623502
What this trial is testing

An Investigation of Kidney and Urothelial Tumor Metabolism in Patients Undergoing Surgical Resection and/or Biopsy

Who this might be right for
Kidney CancerRenal Cell CarcinomaClear Cell Carcinoma+9 more
University of Texas Southwestern Medical Center 600
Early research (Phase 1)Looking for participantsNCT06026410
What this trial is testing

KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors

Who this might be right for
Solid Tumors With HRAS AlterationsNon Small Cell Lung Cancer (NSCLC)Colorectal Cancer (CRC)+4 more
Kura Oncology, Inc. 300
Testing effectiveness (Phase 2)Active Not RecruitingNCT05286294
What this trial is testing

Microbiota Transplant to Cancer Patients Who Have Failed Immunotherapy Using Faeces From Clinical Responders

Who this might be right for
Melanoma Stage IVHead and Neck Squamous Cell CarcinomaCutaneous Squamous Cell Carcinoma+3 more
Oslo University Hospital 20
Testing effectiveness (Phase 2)Study completedNCT00335556
What this trial is testing

Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors

Who this might be right for
Childhood Renal Cell CarcinomaClear Cell Renal Cell CarcinomaClear Cell Sarcoma of the Kidney+10 more
Children's Oncology Group 291
Testing effectiveness (Phase 2)Ended earlyNCT06716853
What this trial is testing

A Clinical Gene Therapy Study With Hematopoietic Stem Cells for the Treatment, With Single Dose of Temferon, of Patients Suffering From Metastatic Renal Cell Carcinoma

Who this might be right for
Clear Cell RCC
Genenta Science 10
Early research (Phase 1)Study completedNCT01625351
What this trial is testing

CD45RA+ Depleted Haploidentical Stem Cell Transplantation in Children With Relapsed or Refractory Solid Tumors and Lymphomas

Who this might be right for
Ewing SarcomaGastrointestinal TumorGerm Cell Tumor+10 more
St. Jude Children's Research Hospital 23
Testing effectiveness (Phase 2)Study completedNCT00126594
What this trial is testing

Sorafenib Tosylate With or Without Recombinant Interferon Alfa-2b in Treating Patients With Metastatic Kidney Cancer

Who this might be right for
Clear Cell Renal Cell CarcinomaRecurrent Renal Cell CarcinomaStage IV Renal Cell Cancer
National Cancer Institute (NCI) 80
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07256223
What this trial is testing

A Clinical Trial of Envafolimab Combined With Lenvatinib for Kidney Cancer With Liver Spread

Who this might be right for
Clear Cell Renal Cell Cancer (ccRCC)Liver Metastasis
Fudan University 30
Not applicableStudy completedNCT00602862
What this trial is testing

Effect of Sorafenib on ccRCC Uptake of Radiolabeled Bevacizumab or cG250

Who this might be right for
Clear Cell Renal Cell Carcinoma
Radboud University Medical Center 26
Testing effectiveness (Phase 2)Active Not RecruitingNCT06964958
What this trial is testing

177LuPSMA in Renal Cell Carcinoma

Who this might be right for
Renal Cell CarcinomaAdvanced Clear Cell Renal Cell CarcinomaKidney Cancer
Dana-Farber Cancer Institute 24
Testing effectiveness (Phase 2)Looking for participantsNCT07389629
What this trial is testing

Iparomlimab and Tuvonralimab (QL1706) Combination With Lenvatinib as Neoadjuvant Therapy for ccRCC

Who this might be right for
Iparomlimab and TuvonralimabClear Cell Renal Cell CarcinomaNeoadjuvant Therapy
Sun Yat-sen University 25
Testing effectiveness (Phase 2)Study completedNCT00729053
What this trial is testing

Study of IMO-2055 in Metastatic or Locally Recurrent Clear Cell Renal Carcinoma

Who this might be right for
Renal Cell Carcinoma
Idera Pharmaceuticals, Inc. 92
Testing effectiveness (Phase 2)Study completedNCT02118337
What this trial is testing

A Phase 1/2, Open-label Study to Evaluate the Safety and Antitumor Activity of MEDI0680 (AMP-514) in Combination With Durvalumab Versus Nivolumab Monotherapy in Participants With Select Advanced Malignancies

Who this might be right for
Select Advanced MalignanciesKidney CancerClear Cell Renal Cell Carcinoma
MedImmune LLC 97
Testing effectiveness (Phase 2)Study completedNCT01158521
What this trial is testing

Pazopanib Hydrochloride Before Surgery in Treating Patients With Kidney Cancer

Who this might be right for
Clear Cell Renal Cell CarcinomaStage I Renal Cell CancerStage II Renal Cell Cancer+1 more
Case Comprehensive Cancer Center 25
Early research (Phase 1)Looking for participantsNCT04897321
What this trial is testing

B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)

Who this might be right for
Pediatric Solid TumorOsteosarcomaRhabdomyosarcoma+13 more
St. Jude Children's Research Hospital 48
Testing effectiveness (Phase 2)Looking for participantsNCT05267626
What this trial is testing

Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer

Who this might be right for
Advanced Solid TumorMetastatic CancerCutaneous Melanoma+1 more
Aulos Bioscience, Inc. 159
Testing effectiveness (Phase 2)Ended earlyNCT01784978
What this trial is testing

Efficacy Study of Sunitinib and Everolimus (Rotational vs Sequential Arm) in Pats. With m Clear Cell Renal Cancer

Who this might be right for
Metastatic Renal Cell Carcinoma
Associació per a la Recerca Oncologica, Spain 41
Testing effectiveness (Phase 2)Study completedNCT00142415
What this trial is testing

Phase I/II Dose-escalation Study of Lutetium-177-labeled cG250 in Patients With Advanced Renal Cancer

Who this might be right for
Metastatic Renal Cell Carcinoma
Ludwig Institute for Cancer Research 26
Testing effectiveness (Phase 2)Study completedNCT03680521
What this trial is testing

Neoadjuvant Sitravatinib in Combination With Nivolumab in Patients With Clear Cell Renal Cell Carcinoma

Who this might be right for
Clear Cell Renal Cell Carcinoma
Mirati Therapeutics Inc. 25
Testing effectiveness (Phase 2)Study completedNCT02989714
What this trial is testing

Phase Ib/II Trial of Interleukin-2 and PD-1 Checkpoint Inhibitor, Nivolumab In Metastatic Clear Cell Renal Cell Cancer

Who this might be right for
Renal Cell Carcinoma
University of Michigan Rogel Cancer Center 13
Next Page